HPV Testing: How It Works, Who Should Get It, and What Your Results Mean

Last updated: June 9, 2026

Quick Answer

An HPV test checks a cervical sample for high-risk HPV types, often alongside a Pap test that looks for abnormal cells. It’s a routine part of cervical screening for women, usually from their mid-20s. There’s no routine HPV test for men. A positive result is common and does not mean you have cancer.

Key Takeaways

HPV testing detects the presence of high-risk human papillomavirus DNA in cervical cells — it does not detect cancer.
A positive HPV result is extremely common; most infections clear on their own without treatment.
The HPV test and the Pap smear are different tools: one looks for the virus, the other looks for abnormal cells.
There is no routine, clinically approved HPV test for men in standard healthcare settings.
Screening ages and intervals vary by country and change as guidelines are updated — always verify current guidance with your clinician or a trusted health authority such as ACOG, USPSTF, or the NHS.
A positive result is not a cancer diagnosis, not a verdict on your relationship, and not a sign that something went wrong recently.
Self-sampling options for HPV testing are increasingly available and show strong accuracy in research settings.
After a positive or abnormal result, next steps are decided with your clinician — do not attempt to interpret results alone.

What Exactly Is HPV Testing and How Does It Work?

HPV testing detects the genetic material (DNA or RNA) of high-risk human papillomavirus strains in a sample of cervical cells. It does not diagnose cancer and does not tell you how long you have had the virus or where it came from.

Human papillomavirus is one of the most common sexually transmitted infections worldwide. The Centers for Disease Control and Prevention (CDC) estimates that nearly all sexually active people will have HPV at some point in their lives. Most infections cause no symptoms and resolve without any intervention. A small subset of high-risk HPV types — particularly HPV 16 and HPV 18 — can, over many years, cause cell changes that may progress to cervical cancer if left undetected and untreated.

How the test works, step by step:

A clinician (or, with self-sampling, the patient) collects cells from the cervix using a small brush or swab.
The sample is sent to a laboratory.
Lab technicians use molecular techniques — typically polymerase chain reaction (PCR) or signal amplification — to detect HPV DNA or RNA.
Results indicate whether high-risk HPV types are present, and some tests identify whether HPV 16 or 18 specifically are detected.

The test does not look at the shape or structure of cells. That is the Pap smear’s job. HPV testing and Pap testing are complementary, not interchangeable.

“A positive HPV test result means the virus is present. It does not mean you have cancer, and it does not mean you will develop cancer.”

Types of HPV Testing: Primary, Co-Testing, Reflex, and Genotyping

There are several forms of HPV screening, and the one you receive depends on your age, prior results, and the guidelines used by your healthcare provider.

Test Type	What It Does	Typical Use
Primary HPV test	Screens for high-risk HPV types alone, without a simultaneous Pap	Preferred first-line screening in some guidelines for ages 25-65
Co-testing	HPV test and Pap smear performed together on the same sample	Widely used; offers high sensitivity
Reflex HPV testing	HPV test triggered automatically when a Pap result is borderline (ASC-US)	Avoids unnecessary follow-up for normal Pap results
HPV 16/18 genotyping	Identifies specifically whether HPV 16 or 18 is present	Used after a positive HPV test to guide next steps

Which type applies to you? That depends on your country’s current guidelines, your age, and your clinical history. In the United States, both the American Cancer Society (ACS) and the U.S. Preventive Services Task Force (USPSTF) have issued guidance on primary HPV testing as a preferred option for many women aged 25 to 65, but co-testing remains widely used. Guidelines are updated periodically, so confirm the current recommendation with your provider.

Who Should Get Tested, and When?

Routine HPV screening is recommended for people with a cervix, generally starting in their mid-20s and continuing through age 65. Exact ages and intervals differ by country and are subject to revision.

General framework (verify current guidelines with your provider):

Ages 21-24: In the U.S., Pap testing alone is typically recommended; HPV testing is generally not recommended in this age group because HPV infections are very common and usually clear on their own.
Ages 25-65: Primary HPV testing every 5 years, co-testing every 5 years, or Pap alone every 3 years, depending on the guideline set your provider follows.
Over 65: Screening may stop if you have had adequate prior screening with normal results. Your clinician will advise.
After a hysterectomy: If the cervix was removed and there is no history of high-grade cell changes or cervical cancer, routine screening is generally not needed.

Higher-risk groups who may need more frequent screening:

People living with HIV
People who are immunocompromised due to organ transplant or long-term immunosuppressive therapy
Those with a history of cervical cancer or high-grade dysplasia
Those with in utero exposure to diethylstilbestrol (DES)

Common mistake: Assuming that because you received the HPV vaccine, you no longer need cervical screening. The vaccine protects against the most dangerous HPV types but does not cover all high-risk strains. Screening continues regardless of vaccination status.

Am I at Risk for HPV If I’m Under 30?

Yes — HPV infection is actually most common in people under 30, but this does not mean routine HPV testing is recommended in that age group. The two facts are related but distinct.

HPV is transmitted through skin-to-skin genital contact. You do not need to have penetrative sex to acquire it, and condoms reduce but do not eliminate transmission. Because the immune system in younger people is generally effective at clearing the virus, most HPV infections in those under 25 resolve within one to two years without causing lasting cell changes.

This is precisely why most guidelines delay HPV co-testing or primary HPV testing until age 25 or later. A positive result in a 22-year-old is very likely to resolve on its own, and aggressive follow-up could lead to unnecessary procedures. The risk-benefit calculation shifts after 25, when persistent infection becomes more clinically meaningful.

If you are under 25 and concerned: Talk to your clinician. A Pap smear may still be appropriate depending on your history, and your provider can advise on whether any additional testing is warranted.

Can Men Get Tested for HPV?

There is no routine, clinically approved HPV test for men in standard healthcare settings. This is not an oversight — it reflects the current state of available tests and clinical evidence.

HPV in men most commonly affects the skin of the penis, scrotum, and anus. There is no validated, widely available test that screens for HPV at these sites in the way that cervical HPV testing works. The FDA has not approved a routine HPV test for penile or scrotal tissue.

What does exist for men:

Anal HPV testing and high-resolution anoscopy are used in some specialist settings for men who have sex with men (MSM), particularly those living with HIV, who face a significantly elevated risk of anal cancer. This is not a standard screening offered to all men.
Visual inspection by a clinician can identify genital warts caused by low-risk HPV types (6 and 11), but this is not the same as a molecular HPV test.

What men can do: Get vaccinated against HPV if eligible (vaccination is approved for males up to age 45 in the U.S.), use condoms consistently, and discuss any concerns with a healthcare provider. Men who have sex with men and are HIV-positive should ask their provider specifically about anal cancer screening.

The absence of a routine test does not mean HPV is not a health concern for men — it means the clinical tools for population-level male screening are not yet established.

How Is the HPV Test Done?

An HPV test is straightforward and typically takes only a few minutes during a standard clinic visit. The process is the same whether the HPV test is performed alone or alongside a Pap smear.

During a clinic visit:

You lie on an exam table with your feet in stirrups.
A clinician inserts a speculum to gently open the vaginal walls.
A small brush or spatula is used to collect cells from the cervix (the lower end of the uterus).
The sample goes into a liquid medium and is sent to a lab.
Results are typically available within one to two weeks, though this varies.

Does it hurt? Most people feel mild pressure or brief discomfort. Some experience light spotting afterward, which is normal.

Self-sampling: An increasingly available alternative allows you to collect your own vaginal sample using a swab, either at home or in a clinic setting without a pelvic exam. Research published in peer-reviewed journals, including a 2019 systematic review in The Lancet Oncology (PMID: 31097399), found that self-collected samples perform comparably to clinician-collected samples for detecting high-risk HPV. Self-sampling is particularly valuable for people who avoid screening due to discomfort, prior trauma, or access barriers. Availability varies by country and healthcare system — ask your provider whether it is an option for you.

What Do HPV Test Results Mean?

An HPV-positive result means high-risk HPV DNA was detected in your sample. It does not mean you have cancer, and it does not tell you when you acquired the infection or from whom.

Breaking down the possible results:

HPV Negative:

No high-risk HPV types were detected.
If your Pap was also normal, your risk of developing cervical cancer in the next several years is very low.
Routine screening continues on the schedule recommended by your provider.

HPV Positive, Pap Normal:

High-risk HPV is present, but no abnormal cells were found.
This is a common result. Your clinician will likely recommend a repeat test in 12 months or HPV 16/18 genotyping to determine next steps.
Most infections clear without treatment.

HPV Positive, Pap Abnormal:

Both the virus and cell changes are present.
The degree of cell change (mild, moderate, or severe) guides next steps.
Your clinician may refer you for colposcopy — a closer examination of the cervix.

HPV Negative, Pap Abnormal:

Cell changes exist but high-risk HPV was not detected.
Follow-up depends on the type and degree of abnormality.

Key point: A positive HPV result is not a crisis. It is a signal that closer monitoring is appropriate. The vast majority of people with a positive HPV test never develop cervical cancer.

HPV Test vs Pap Smear: What Is the Difference?

The HPV test and the Pap smear are different tests that measure different things, though they are often performed together using the same cervical sample.

Feature	HPV Test	Pap Smear (Pap Test)
What it detects	High-risk HPV virus (DNA/RNA)	Abnormal or precancerous cervical cells
What a positive means	Virus is present	Cell changes are present
Can it diagnose cancer?	No	No (biopsy is needed for diagnosis)
Used for	Screening for HPV infection	Screening for cervical cell changes
Same sample?	Often yes, in co-testing	Often yes, in co-testing

The critical distinction: A Pap smear can be abnormal even when HPV is not detected, and an HPV test can be positive even when the Pap is completely normal. Neither test alone gives the full picture, which is why co-testing is common.

Many people use “Pap smear” to mean any cervical screening test, but the two are not the same. If you are unsure which test you received, ask your provider or check your lab report.

What Happens After an Abnormal or Positive HPV Test Result?

Next steps after a positive or abnormal result depend on the specific combination of findings, your age, and your medical history. Do not try to interpret results or plan next steps without your clinician.

Common pathways:

HPV positive, normal Pap, no genotyping: Repeat co-testing or primary HPV test in 12 months. If the infection clears, return to routine screening. If it persists, further evaluation is needed.
HPV 16 or 18 positive (regardless of Pap result): Referral for colposcopy is typically recommended, because these strains carry the highest cancer risk.
Abnormal Pap (any grade), HPV positive: Colposcopy is usually recommended.
High-grade Pap abnormality (HSIL): Colposcopy and likely biopsy, regardless of HPV status.

What is a colposcopy? A colposcopy is an in-office procedure where a clinician uses a magnifying instrument to examine the cervix closely. If abnormal areas are visible, a small tissue sample (biopsy) may be taken. Results from the biopsy determine whether treatment is needed.

Treatment, if needed: If a biopsy confirms precancerous changes (cervical intraepithelial neoplasia, or CIN), treatment options include procedures to remove or destroy the affected tissue. These are highly effective when caught early. Cervical cancer itself, if detected, is managed by an oncology team.

Emotional impact: Getting a positive result can be stressful. It is worth knowing that the screening system is working exactly as intended when it catches an HPV infection early. Discuss any concerns — medical or emotional — with your provider.

How Much Does an HPV Test Cost Without Insurance?

Without insurance, an HPV test in the United States typically costs between $30 and $100 for the test itself, but the total cost of a screening visit can be significantly higher when you factor in the clinic consultation fee.

Cost breakdown (approximate, U.S. 2026):

HPV test alone (lab fee): $30-$100
Pap smear (lab fee): $30-$75
Office visit / consultation: $100-$250 or more, depending on the provider
Co-testing (HPV + Pap, lab only): $50-$150

Ways to reduce cost:

Planned Parenthood: Offers HPV testing and cervical screening on a sliding-scale fee based on income. Many people pay little or nothing. Services are available at clinics nationwide.
Community health centers (FQHCs): Federally Qualified Health Centers provide care regardless of ability to pay, also on a sliding scale.
Title X family planning clinics: Provide low-cost or free reproductive health services, including cervical screening.
State programs: Many U.S. states have free or low-cost cervical cancer screening programs. The CDC’s National Breast and Cervical Cancer Early Detection Program (NBCCEDP) funds free screening for low-income, uninsured, and underinsured women.

Outside the U.S., HPV testing is typically covered as part of national cervical screening programs (for example, the NHS in England invites eligible people for free cervical screening).

Do At-Home HPV Tests Really Work?

At-home HPV self-sampling tests are real, increasingly available, and supported by a growing body of clinical evidence. However, their regulatory status and availability vary significantly by country.

What the evidence says: The 2019 Lancet Oncology systematic review (PMID: 31097399) of over 56 studies found that self-collected vaginal samples were comparable to clinician-collected cervical samples for detecting high-risk HPV using molecular testing. Sensitivity for detecting CIN2 or worse was similar between collection methods.

What “at-home” means in practice:

You receive a kit, collect a vaginal swab yourself, and mail it to a lab.
Results are returned digitally, often within a few days.
A positive result still requires follow-up with a clinician — the at-home test does not replace the clinical pathway.

Limitations:

Self-sampling collects a vaginal sample, not a cervical sample. For some test platforms, this difference in sample site can affect sensitivity.
At-home tests are not a substitute for a full cervical screening visit that includes a Pap smear.
In the U.S., the FDA has cleared some self-collection options for use in clinical settings, but fully home-based mail-in kits are still emerging in terms of regulatory approval and clinical integration.

Verdict: At-home HPV testing is a promising tool for increasing screening uptake, particularly for people who face barriers to clinic visits. If you use one, treat a positive result as a prompt to see a clinician, not as a standalone diagnosis.

How Accurate Are HPV Screening Methods?

Clinician-collected HPV tests using FDA-approved molecular assays have high sensitivity for detecting high-risk HPV. Sensitivity for detecting CIN2 or worse (the threshold at which treatment is typically considered) is generally reported above 90% in clinical studies, though exact figures vary by assay and population.

Factors that affect accuracy:

Sample quality: An inadequate sample can lead to an inconclusive result. This is more common with self-sampling but can occur with clinician collection too.
Test type: Not all HPV tests are equal. FDA-approved assays used in certified labs are the standard of care. Point-of-care tests and unvalidated commercial kits vary widely.
Lab quality: Results depend on laboratory standards and proficiency.
Timing: HPV tests can be falsely negative if the viral load is very low at the time of sampling.

False positives and false negatives:

A false positive (test says HPV is present when it is not) can lead to unnecessary follow-up procedures.
A false negative (test misses an existing infection) is the more serious concern from a cancer prevention standpoint.

Co-testing (HPV + Pap together) has higher combined sensitivity than either test alone, which is one reason it remains widely used despite the added cost.

Key point: No screening test is 100% accurate. This is why regular, repeat screening over time is more protective than a single test.

Common Mistakes People Make About HPV Testing

Several widespread misconceptions lead people to either avoid testing unnecessarily or misinterpret their results.

Mistake 1: Thinking a positive result means you or your partner cheated.
HPV can remain dormant for years or decades before being detected. A positive result tells you nothing about when or from whom you acquired the virus.

Mistake 2: Stopping screening after HPV vaccination.
The vaccine is highly effective against the most dangerous HPV types, but it does not cover all high-risk strains. Screening continues after vaccination.

Mistake 3: Assuming a normal Pap means no HPV.
A Pap smear checks for cell changes, not the virus itself. You can have HPV and a completely normal Pap.

Mistake 4: Seeking an HPV test for men through standard channels.
No routine approved HPV test exists for men. Asking a general practitioner for one will typically result in a conversation about why it is not available, not a test.

Mistake 5: Treating a positive result as a cancer diagnosis.
A positive HPV test is a common finding. The clinical pathway that follows is designed to monitor and intervene long before cancer develops.

Mistake 6: Skipping follow-up after a positive result.
The screening system only works if you complete the follow-up steps your clinician recommends. Ignoring a positive result removes the protective benefit of screening.

Which HPV Strains Are Most Dangerous?

Of the approximately 14 high-risk HPV genotypes identified by the World Health Organization (WHO), two stand out as the most clinically significant.

HPV 16: Associated with approximately 50-60% of cervical cancers globally (WHO). Also linked to oropharyngeal cancers, anal cancers, and some vulvar and penile cancers.
HPV 18: Associated with approximately 10-15% of cervical cancers. More commonly linked to adenocarcinoma of the cervix (a glandular cell type that is harder to detect on Pap smear).

Other high-risk types include HPV 31, 33, 45, 52, and 58, among others. These are detected by most FDA-approved HPV assays but are not individually identified unless extended genotyping is performed.

Low-risk types (not cancer-causing):

HPV 6 and HPV 11 cause approximately 90% of genital warts. They are not associated with cervical cancer and are not detected by high-risk HPV screening tests.

Why genotyping matters: When an HPV test comes back positive, knowing whether HPV 16 or 18 is specifically present changes the clinical pathway. A positive for 16 or 18 typically leads to colposcopy regardless of the Pap result, because the cancer risk is higher with these specific types.

FAQ

What is an HPV test?

An HPV test checks a sample of cervical cells for the presence of high-risk human papillomavirus DNA or RNA. It is used as part of routine cervical cancer screening and is often performed alongside a Pap smear. The test does not diagnose cancer.

Does a positive HPV result mean I have cancer?

No. A positive HPV result means the virus was detected. Most HPV infections clear on their own within one to two years. A positive result triggers closer monitoring, not a cancer diagnosis. Cervical cancer develops only in a small fraction of people with persistent, untreated high-risk HPV infection over many years.

Can men be tested for HPV?

There is no routine, clinically approved HPV test for men in standard healthcare settings. Anal HPV testing exists in specialist settings for high-risk groups (such as men who have sex with men and are HIV-positive), but this is not a general screening tool. Men can reduce their risk through HPV vaccination and consistent condom use.

What is the difference between an HPV test and a Pap smear?

An HPV test detects the virus. A Pap smear detects abnormal cervical cells. They are different tests that can be performed on the same sample. A normal Pap does not rule out HPV, and a positive HPV test does not mean cells are abnormal. Both tests together (co-testing) provide the most complete picture.

What happens after an abnormal result?

Next steps depend on the specific combination of HPV and Pap findings, your age, and your history. Common follow-up options include a repeat test in 12 months, HPV 16/18 genotyping, or referral for colposcopy. Your clinician will recommend the appropriate pathway. Do not attempt to manage results without professional guidance.

Can I get an HPV test at Planned Parenthood?

Yes. Planned Parenthood clinics offer HPV testing and Pap smears as part of their reproductive health services. Fees are based on a sliding scale tied to income, and many patients pay little or nothing. Services are available at clinics across the United States.

How often should I get HPV screening?

Screening frequency depends on your age, country, and the type of test used. In the U.S., common intervals are every 3 years (Pap alone), every 5 years (primary HPV test or co-testing), or as directed by your clinician based on prior results. Guidelines change over time — verify the current recommendation with your provider.

Are at-home HPV tests accurate?

Self-collected vaginal samples show comparable accuracy to clinician-collected cervical samples for high-risk HPV detection in multiple clinical studies. However, at-home kits vary in quality and regulatory status. A positive at-home result always requires follow-up with a clinician. At-home testing does not replace a full cervical screening visit.

What does HPV 16 or 18 positive mean?

HPV 16 and 18 are the two highest-risk HPV types, responsible for the majority of HPV-related cervical cancers. A positive result for either type typically leads directly to colposcopy, regardless of the Pap result, because the risk of precancerous changes is higher with these specific strains.

How much does HPV testing cost without insurance?

In the U.S., the lab fee for an HPV test typically ranges from $30 to $100. When combined with a clinic visit, total costs can reach $200-$350 or more. Low-cost options include Planned Parenthood, federally qualified health centers, and the CDC’s NBCCEDP program for eligible individuals.

Conclusion

HPV testing is one of the most effective tools available for preventing cervical cancer. By detecting high-risk HPV types before cell changes progress, the screening system gives clinicians and patients time to monitor, intervene, and prevent harm. A positive result is not a crisis — it is the system working as designed.

Actionable next steps:

If you have a cervix and are between 25 and 65, confirm with your provider when your next cervical screening is due and which type of test is appropriate for you.
If you received a positive HPV result, do not wait. Schedule a follow-up appointment and ask your provider specifically what the result means for your next step.
If you have been vaccinated against HPV, continue attending regular cervical screening — vaccination does not eliminate the need for testing.
If cost or access is a barrier, contact Planned Parenthood, a local community health center, or your state health department to find free or low-cost screening options.
If you are a man concerned about HPV, speak with your provider about vaccination eligibility and discuss whether anal cancer screening is appropriate given your specific risk profile.

The most important thing you can do is stay current with screening. Early detection through routine HPV testing saves lives.

References

U.S. Preventive Services Task Force (USPSTF). Cervical Cancer Screening Recommendation Statement. 2018. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening
American Cancer Society (ACS). Cervical Cancer Screening Guidelines. 2020. https://www.cancer.org/cancer/cervical-cancer/detection-diagnosis-staging/cervical-cancer-screening-guidelines.html
American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. 2016 (reaffirmed 2021). https://www.acog.org
Centers for Disease Control and Prevention (CDC). HPV Fact Sheet. https://www.cdc.gov/std/hpv/stdfact-hpv.htm
NHS England. Cervical Screening (Smear Test). https://www.nhs.uk/conditions/cervical-screening/
World Health Organization (WHO). Human Papillomavirus (HPV) and Cervical Cancer. https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
Arbyn M, et al. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. The Lancet Oncology. 2019. PMID: 31097399. DOI: 10.1016/S1470-2045(19)30064-9
National Cancer Institute (NCI). Cervical Cancer Screening (PDQ). https://www.cancer.gov/types/cervical/patient/cervical-screening-pdq

Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions about your health.

Author: Dr. Laura Bennett, OB/GYN — Board-Certified Gynecologist, Women’s Integrative Health Center (Private Practice) | Sources: WHO, CDC, ACOG, NHS, NCI, peer-reviewed literature | Last updated: June 9, 2026

Table of Contents